CSRP2 and glioblastoma: Furthermore, we found elevated CSRP2 expression in the mesenchymal type of GBM compared to the proneural type (Fig. 1B, C), and in GBM patients who had undergone chemotherapy (status 1) compared to those without chemotherapy (status 0) (Fig. 1D).